ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Liposome Development Service Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-36V11246
Home | Market Reports | Business & Industrial| Business Services
Global Liposome Development Service Market Research Report 2022
BUY CHAPTERS

Global Liposome Development Service Market Research Report 2025

Code: QYRE-Auto-36V11246
Report
March 2025
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Creative-Biolabs
Creative Biostructure
Evonik
PlantaCorp
CD Bioparticles
Exelead
T&T Scientific
FormuMax Scientific
Precision Nanosystems
Merck KGaA
Genevant Sciences
Avanti Polar Lipids
Nippon Fine Chemical
Lipoid
Polymun Scientific
Corden Pharma
Acuitas Therapeutics

Liposome Development Service Market Size

The global market for Liposome Development Service was valued at US$ 1217 million in the year 2024 and is projected to reach a revised size of US$ 2079 million by 2031, growing at a CAGR of 8.1% during the forecast period.

Liposome Development Service Market

Liposome Development Service Market

Liposomes are a type of nano-sized phospholipid bubbles, which have attracted much attention as potential drug carriers. Liposomes are highly biocompatible and easy to control in vivo and can be loaded with a broad variety of drugs, DNA, and diagnostic agents. To date, a variety of liposomal drugs are under development and some of them are already approved for clinical use.
Market Driver
The liposome development service market is driven by the growing demand for advanced drug delivery systems that enhance the bioavailability, efficacy, and safety of therapeutics. Liposomes, being biocompatible and capable of targeted drug delivery, are increasingly used in the development of treatments for cancer, infectious diseases, and vaccines. Additionally, the rise in biologics and personalized medicine, coupled with advancements in nanotechnology, supports the growth of the liposome development service market.
Market Challenge
Despite its potential, the liposome development service market faces challenges such as high production costs and complex manufacturing processes that require specialized expertise and facilities. Regulatory hurdles in the approval of liposome-based therapies and the potential for stability issues during storage and transportation further constrain the market's growth. These factors create barriers, particularly for smaller companies with limited resources.
Global key players of liposome development service include Precision NanoSystems, Evonik, Merck KGaA, Genevant Sciences, Exelead, etc. The top two players hold a share over 52%. North America is the largest market, has a share about 61%, followed by Europe and Asia-Pacific, with share 26% and 11%, separately. In terms of product type, Lipid Nanoparticles is the largest segment, occupied for a share of 62%, and in terms of application, Commercial has a share about 86 percent.
This report aims to provide a comprehensive presentation of the global market for Liposome Development Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liposome Development Service.
The Liposome Development Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Liposome Development Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Liposome Development Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Liposome Development Service Market Report

Report Metric Details
Report Name Liposome Development Service Market
Accounted market size in year US$ 1217 million
Forecasted market size in 2031 US$ 2079 million
CAGR 8.1%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Liposomes
  • Lipid Nanoparticles
Segment by Application
  • Preclinical
  • Clinical
  • Commercial
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Precision NanoSystems, Evonik, Merck KGaA, Genevant Sciences, Exelead, Avanti Polar Lipids, Nippon Fine Chemical, Lipoid, Polymun Scientific, Corden Pharma, Acuitas Therapeutics, Creative Biolabs, Creative Biostructure, T&T Scientific, FormuMax Scientific, PlantaCorp, CD Bioparticles
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Liposome Development Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Liposome Development Service Market growing?

Ans: The Liposome Development Service Market witnessing a CAGR of 8.1% during the forecast period 2025-2031.

What is the Liposome Development Service Market size in 2031?

Ans: The Liposome Development Service Market size in 2031 will be US$ 2079 million.

What is the market share of major companies in Liposome Development Service Market?

Ans: The top two players hold a share over 52%.

What is the Liposome Development Service Market share by region?

Ans: North America is the largest market, has a share about 61%, followed by Europe and Asia-Pacific, with share 26% and 11%, separately.

What is the Liposome Development Service Market share by type?

Ans: In terms of product type, Lipid Nanoparticles is the largest segment, occupied for a share of 62%, and in terms of application, Commercial has a share about 86 percent.

Who are the main players in the Liposome Development Service Market report?

Ans: The main players in the Liposome Development Service Market are Precision NanoSystems, Evonik, Merck KGaA, Genevant Sciences, Exelead, Avanti Polar Lipids, Nippon Fine Chemical, Lipoid, Polymun Scientific, Corden Pharma, Acuitas Therapeutics, Creative Biolabs, Creative Biostructure, T&T Scientific, FormuMax Scientific, PlantaCorp, CD Bioparticles

What are the Application segmentation covered in the Liposome Development Service Market report?

Ans: The Applications covered in the Liposome Development Service Market report are Preclinical, Clinical, Commercial

What are the Type segmentation covered in the Liposome Development Service Market report?

Ans: The Types covered in the Liposome Development Service Market report are Liposomes, Lipid Nanoparticles

Recommended Reports

Drug Delivery Solutions

Lipid Nanoparticle Markets

Development Services

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Liposome Development Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Liposomes
1.2.3 Lipid Nanoparticles
1.3 Market by Application
1.3.1 Global Liposome Development Service Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Preclinical
1.3.3 Clinical
1.3.4 Commercial
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Liposome Development Service Market Perspective (2020-2031)
2.2 Global Liposome Development Service Growth Trends by Region
2.2.1 Global Liposome Development Service Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Liposome Development Service Historic Market Size by Region (2020-2025)
2.2.3 Liposome Development Service Forecasted Market Size by Region (2026-2031)
2.3 Liposome Development Service Market Dynamics
2.3.1 Liposome Development Service Industry Trends
2.3.2 Liposome Development Service Market Drivers
2.3.3 Liposome Development Service Market Challenges
2.3.4 Liposome Development Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Liposome Development Service Players by Revenue
3.1.1 Global Top Liposome Development Service Players by Revenue (2020-2025)
3.1.2 Global Liposome Development Service Revenue Market Share by Players (2020-2025)
3.2 Global Liposome Development Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Liposome Development Service Revenue
3.4 Global Liposome Development Service Market Concentration Ratio
3.4.1 Global Liposome Development Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Liposome Development Service Revenue in 2024
3.5 Global Key Players of Liposome Development Service Head office and Area Served
3.6 Global Key Players of Liposome Development Service, Product and Application
3.7 Global Key Players of Liposome Development Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Liposome Development Service Breakdown Data by Type
4.1 Global Liposome Development Service Historic Market Size by Type (2020-2025)
4.2 Global Liposome Development Service Forecasted Market Size by Type (2026-2031)
5 Liposome Development Service Breakdown Data by Application
5.1 Global Liposome Development Service Historic Market Size by Application (2020-2025)
5.2 Global Liposome Development Service Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Liposome Development Service Market Size (2020-2031)
6.2 North America Liposome Development Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Liposome Development Service Market Size by Country (2020-2025)
6.4 North America Liposome Development Service Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Liposome Development Service Market Size (2020-2031)
7.2 Europe Liposome Development Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Liposome Development Service Market Size by Country (2020-2025)
7.4 Europe Liposome Development Service Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Liposome Development Service Market Size (2020-2031)
8.2 Asia-Pacific Liposome Development Service Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Liposome Development Service Market Size by Region (2020-2025)
8.4 Asia-Pacific Liposome Development Service Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Liposome Development Service Market Size (2020-2031)
9.2 Latin America Liposome Development Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Liposome Development Service Market Size by Country (2020-2025)
9.4 Latin America Liposome Development Service Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Liposome Development Service Market Size (2020-2031)
10.2 Middle East & Africa Liposome Development Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Liposome Development Service Market Size by Country (2020-2025)
10.4 Middle East & Africa Liposome Development Service Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Precision NanoSystems
11.1.1 Precision NanoSystems Company Details
11.1.2 Precision NanoSystems Business Overview
11.1.3 Precision NanoSystems Liposome Development Service Introduction
11.1.4 Precision NanoSystems Revenue in Liposome Development Service Business (2020-2025)
11.1.5 Precision NanoSystems Recent Development
11.2 Evonik
11.2.1 Evonik Company Details
11.2.2 Evonik Business Overview
11.2.3 Evonik Liposome Development Service Introduction
11.2.4 Evonik Revenue in Liposome Development Service Business (2020-2025)
11.2.5 Evonik Recent Development
11.3 Merck KGaA
11.3.1 Merck KGaA Company Details
11.3.2 Merck KGaA Business Overview
11.3.3 Merck KGaA Liposome Development Service Introduction
11.3.4 Merck KGaA Revenue in Liposome Development Service Business (2020-2025)
11.3.5 Merck KGaA Recent Development
11.4 Genevant Sciences
11.4.1 Genevant Sciences Company Details
11.4.2 Genevant Sciences Business Overview
11.4.3 Genevant Sciences Liposome Development Service Introduction
11.4.4 Genevant Sciences Revenue in Liposome Development Service Business (2020-2025)
11.4.5 Genevant Sciences Recent Development
11.5 Exelead
11.5.1 Exelead Company Details
11.5.2 Exelead Business Overview
11.5.3 Exelead Liposome Development Service Introduction
11.5.4 Exelead Revenue in Liposome Development Service Business (2020-2025)
11.5.5 Exelead Recent Development
11.6 Avanti Polar Lipids
11.6.1 Avanti Polar Lipids Company Details
11.6.2 Avanti Polar Lipids Business Overview
11.6.3 Avanti Polar Lipids Liposome Development Service Introduction
11.6.4 Avanti Polar Lipids Revenue in Liposome Development Service Business (2020-2025)
11.6.5 Avanti Polar Lipids Recent Development
11.7 Nippon Fine Chemical
11.7.1 Nippon Fine Chemical Company Details
11.7.2 Nippon Fine Chemical Business Overview
11.7.3 Nippon Fine Chemical Liposome Development Service Introduction
11.7.4 Nippon Fine Chemical Revenue in Liposome Development Service Business (2020-2025)
11.7.5 Nippon Fine Chemical Recent Development
11.8 Lipoid
11.8.1 Lipoid Company Details
11.8.2 Lipoid Business Overview
11.8.3 Lipoid Liposome Development Service Introduction
11.8.4 Lipoid Revenue in Liposome Development Service Business (2020-2025)
11.8.5 Lipoid Recent Development
11.9 Polymun Scientific
11.9.1 Polymun Scientific Company Details
11.9.2 Polymun Scientific Business Overview
11.9.3 Polymun Scientific Liposome Development Service Introduction
11.9.4 Polymun Scientific Revenue in Liposome Development Service Business (2020-2025)
11.9.5 Polymun Scientific Recent Development
11.10 Corden Pharma
11.10.1 Corden Pharma Company Details
11.10.2 Corden Pharma Business Overview
11.10.3 Corden Pharma Liposome Development Service Introduction
11.10.4 Corden Pharma Revenue in Liposome Development Service Business (2020-2025)
11.10.5 Corden Pharma Recent Development
11.11 Acuitas Therapeutics
11.11.1 Acuitas Therapeutics Company Details
11.11.2 Acuitas Therapeutics Business Overview
11.11.3 Acuitas Therapeutics Liposome Development Service Introduction
11.11.4 Acuitas Therapeutics Revenue in Liposome Development Service Business (2020-2025)
11.11.5 Acuitas Therapeutics Recent Development
11.12 Creative Biolabs
11.12.1 Creative Biolabs Company Details
11.12.2 Creative Biolabs Business Overview
11.12.3 Creative Biolabs Liposome Development Service Introduction
11.12.4 Creative Biolabs Revenue in Liposome Development Service Business (2020-2025)
11.12.5 Creative Biolabs Recent Development
11.13 Creative Biostructure
11.13.1 Creative Biostructure Company Details
11.13.2 Creative Biostructure Business Overview
11.13.3 Creative Biostructure Liposome Development Service Introduction
11.13.4 Creative Biostructure Revenue in Liposome Development Service Business (2020-2025)
11.13.5 Creative Biostructure Recent Development
11.14 T&T Scientific
11.14.1 T&T Scientific Company Details
11.14.2 T&T Scientific Business Overview
11.14.3 T&T Scientific Liposome Development Service Introduction
11.14.4 T&T Scientific Revenue in Liposome Development Service Business (2020-2025)
11.14.5 T&T Scientific Recent Development
11.15 FormuMax Scientific
11.15.1 FormuMax Scientific Company Details
11.15.2 FormuMax Scientific Business Overview
11.15.3 FormuMax Scientific Liposome Development Service Introduction
11.15.4 FormuMax Scientific Revenue in Liposome Development Service Business (2020-2025)
11.15.5 FormuMax Scientific Recent Development
11.16 PlantaCorp
11.16.1 PlantaCorp Company Details
11.16.2 PlantaCorp Business Overview
11.16.3 PlantaCorp Liposome Development Service Introduction
11.16.4 PlantaCorp Revenue in Liposome Development Service Business (2020-2025)
11.16.5 PlantaCorp Recent Development
11.17 CD Bioparticles
11.17.1 CD Bioparticles Company Details
11.17.2 CD Bioparticles Business Overview
11.17.3 CD Bioparticles Liposome Development Service Introduction
11.17.4 CD Bioparticles Revenue in Liposome Development Service Business (2020-2025)
11.17.5 CD Bioparticles Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Creative-Biolabs
Creative Biostructure
Evonik
PlantaCorp
CD Bioparticles
Exelead
T&T Scientific
FormuMax Scientific
Precision Nanosystems
Merck KGaA
Genevant Sciences
Avanti Polar Lipids
Nippon Fine Chemical
Lipoid
Polymun Scientific
Corden Pharma
Acuitas Therapeutics
List of Tables
 Table 1. Global Liposome Development Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Liposomes
 Table 3. Key Players of Lipid Nanoparticles
 Table 4. Global Liposome Development Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Liposome Development Service Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Liposome Development Service Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Liposome Development Service Market Share by Region (2020-2025)
 Table 8. Global Liposome Development Service Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Liposome Development Service Market Share by Region (2026-2031)
 Table 10. Liposome Development Service Market Trends
 Table 11. Liposome Development Service Market Drivers
 Table 12. Liposome Development Service Market Challenges
 Table 13. Liposome Development Service Market Restraints
 Table 14. Global Liposome Development Service Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Liposome Development Service Market Share by Players (2020-2025)
 Table 16. Global Top Liposome Development Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liposome Development Service as of 2024)
 Table 17. Ranking of Global Top Liposome Development Service Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Liposome Development Service Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Liposome Development Service, Headquarters and Area Served
 Table 20. Global Key Players of Liposome Development Service, Product and Application
 Table 21. Global Key Players of Liposome Development Service, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Liposome Development Service Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Liposome Development Service Revenue Market Share by Type (2020-2025)
 Table 25. Global Liposome Development Service Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Liposome Development Service Revenue Market Share by Type (2026-2031)
 Table 27. Global Liposome Development Service Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Liposome Development Service Revenue Market Share by Application (2020-2025)
 Table 29. Global Liposome Development Service Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Liposome Development Service Revenue Market Share by Application (2026-2031)
 Table 31. North America Liposome Development Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Liposome Development Service Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Liposome Development Service Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Liposome Development Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Liposome Development Service Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Liposome Development Service Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Liposome Development Service Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Liposome Development Service Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Liposome Development Service Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Liposome Development Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Liposome Development Service Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Liposome Development Service Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Liposome Development Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Liposome Development Service Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Liposome Development Service Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Precision NanoSystems Company Details
 Table 47. Precision NanoSystems Business Overview
 Table 48. Precision NanoSystems Liposome Development Service Product
 Table 49. Precision NanoSystems Revenue in Liposome Development Service Business (2020-2025) & (US$ Million)
 Table 50. Precision NanoSystems Recent Development
 Table 51. Evonik Company Details
 Table 52. Evonik Business Overview
 Table 53. Evonik Liposome Development Service Product
 Table 54. Evonik Revenue in Liposome Development Service Business (2020-2025) & (US$ Million)
 Table 55. Evonik Recent Development
 Table 56. Merck KGaA Company Details
 Table 57. Merck KGaA Business Overview
 Table 58. Merck KGaA Liposome Development Service Product
 Table 59. Merck KGaA Revenue in Liposome Development Service Business (2020-2025) & (US$ Million)
 Table 60. Merck KGaA Recent Development
 Table 61. Genevant Sciences Company Details
 Table 62. Genevant Sciences Business Overview
 Table 63. Genevant Sciences Liposome Development Service Product
 Table 64. Genevant Sciences Revenue in Liposome Development Service Business (2020-2025) & (US$ Million)
 Table 65. Genevant Sciences Recent Development
 Table 66. Exelead Company Details
 Table 67. Exelead Business Overview
 Table 68. Exelead Liposome Development Service Product
 Table 69. Exelead Revenue in Liposome Development Service Business (2020-2025) & (US$ Million)
 Table 70. Exelead Recent Development
 Table 71. Avanti Polar Lipids Company Details
 Table 72. Avanti Polar Lipids Business Overview
 Table 73. Avanti Polar Lipids Liposome Development Service Product
 Table 74. Avanti Polar Lipids Revenue in Liposome Development Service Business (2020-2025) & (US$ Million)
 Table 75. Avanti Polar Lipids Recent Development
 Table 76. Nippon Fine Chemical Company Details
 Table 77. Nippon Fine Chemical Business Overview
 Table 78. Nippon Fine Chemical Liposome Development Service Product
 Table 79. Nippon Fine Chemical Revenue in Liposome Development Service Business (2020-2025) & (US$ Million)
 Table 80. Nippon Fine Chemical Recent Development
 Table 81. Lipoid Company Details
 Table 82. Lipoid Business Overview
 Table 83. Lipoid Liposome Development Service Product
 Table 84. Lipoid Revenue in Liposome Development Service Business (2020-2025) & (US$ Million)
 Table 85. Lipoid Recent Development
 Table 86. Polymun Scientific Company Details
 Table 87. Polymun Scientific Business Overview
 Table 88. Polymun Scientific Liposome Development Service Product
 Table 89. Polymun Scientific Revenue in Liposome Development Service Business (2020-2025) & (US$ Million)
 Table 90. Polymun Scientific Recent Development
 Table 91. Corden Pharma Company Details
 Table 92. Corden Pharma Business Overview
 Table 93. Corden Pharma Liposome Development Service Product
 Table 94. Corden Pharma Revenue in Liposome Development Service Business (2020-2025) & (US$ Million)
 Table 95. Corden Pharma Recent Development
 Table 96. Acuitas Therapeutics Company Details
 Table 97. Acuitas Therapeutics Business Overview
 Table 98. Acuitas Therapeutics Liposome Development Service Product
 Table 99. Acuitas Therapeutics Revenue in Liposome Development Service Business (2020-2025) & (US$ Million)
 Table 100. Acuitas Therapeutics Recent Development
 Table 101. Creative Biolabs Company Details
 Table 102. Creative Biolabs Business Overview
 Table 103. Creative Biolabs Liposome Development Service Product
 Table 104. Creative Biolabs Revenue in Liposome Development Service Business (2020-2025) & (US$ Million)
 Table 105. Creative Biolabs Recent Development
 Table 106. Creative Biostructure Company Details
 Table 107. Creative Biostructure Business Overview
 Table 108. Creative Biostructure Liposome Development Service Product
 Table 109. Creative Biostructure Revenue in Liposome Development Service Business (2020-2025) & (US$ Million)
 Table 110. Creative Biostructure Recent Development
 Table 111. T&T Scientific Company Details
 Table 112. T&T Scientific Business Overview
 Table 113. T&T Scientific Liposome Development Service Product
 Table 114. T&T Scientific Revenue in Liposome Development Service Business (2020-2025) & (US$ Million)
 Table 115. T&T Scientific Recent Development
 Table 116. FormuMax Scientific Company Details
 Table 117. FormuMax Scientific Business Overview
 Table 118. FormuMax Scientific Liposome Development Service Product
 Table 119. FormuMax Scientific Revenue in Liposome Development Service Business (2020-2025) & (US$ Million)
 Table 120. FormuMax Scientific Recent Development
 Table 121. PlantaCorp Company Details
 Table 122. PlantaCorp Business Overview
 Table 123. PlantaCorp Liposome Development Service Product
 Table 124. PlantaCorp Revenue in Liposome Development Service Business (2020-2025) & (US$ Million)
 Table 125. PlantaCorp Recent Development
 Table 126. CD Bioparticles Company Details
 Table 127. CD Bioparticles Business Overview
 Table 128. CD Bioparticles Liposome Development Service Product
 Table 129. CD Bioparticles Revenue in Liposome Development Service Business (2020-2025) & (US$ Million)
 Table 130. CD Bioparticles Recent Development
 Table 131. Research Programs/Design for This Report
 Table 132. Key Data Information from Secondary Sources
 Table 133. Key Data Information from Primary Sources
 Table 134. Authors List of This Report


List of Figures
 Figure 1. Liposome Development Service Picture
 Figure 2. Global Liposome Development Service Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Liposome Development Service Market Share by Type: 2024 VS 2031
 Figure 4. Liposomes Features
 Figure 5. Lipid Nanoparticles Features
 Figure 6. Global Liposome Development Service Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Liposome Development Service Market Share by Application: 2024 VS 2031
 Figure 8. Preclinical Case Studies
 Figure 9. Clinical Case Studies
 Figure 10. Commercial Case Studies
 Figure 11. Liposome Development Service Report Years Considered
 Figure 12. Global Liposome Development Service Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global Liposome Development Service Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Liposome Development Service Market Share by Region: 2024 VS 2031
 Figure 15. Global Liposome Development Service Market Share by Players in 2024
 Figure 16. Global Top Liposome Development Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liposome Development Service as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by Liposome Development Service Revenue in 2024
 Figure 18. North America Liposome Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America Liposome Development Service Market Share by Country (2020-2031)
 Figure 20. United States Liposome Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada Liposome Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Liposome Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Liposome Development Service Market Share by Country (2020-2031)
 Figure 24. Germany Liposome Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France Liposome Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. Liposome Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy Liposome Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia Liposome Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries Liposome Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Liposome Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Liposome Development Service Market Share by Region (2020-2031)
 Figure 32. China Liposome Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan Liposome Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea Liposome Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia Liposome Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India Liposome Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia Liposome Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Liposome Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Liposome Development Service Market Share by Country (2020-2031)
 Figure 40. Mexico Liposome Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil Liposome Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Liposome Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Liposome Development Service Market Share by Country (2020-2031)
 Figure 44. Turkey Liposome Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia Liposome Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE Liposome Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Precision NanoSystems Revenue Growth Rate in Liposome Development Service Business (2020-2025)
 Figure 48. Evonik Revenue Growth Rate in Liposome Development Service Business (2020-2025)
 Figure 49. Merck KGaA Revenue Growth Rate in Liposome Development Service Business (2020-2025)
 Figure 50. Genevant Sciences Revenue Growth Rate in Liposome Development Service Business (2020-2025)
 Figure 51. Exelead Revenue Growth Rate in Liposome Development Service Business (2020-2025)
 Figure 52. Avanti Polar Lipids Revenue Growth Rate in Liposome Development Service Business (2020-2025)
 Figure 53. Nippon Fine Chemical Revenue Growth Rate in Liposome Development Service Business (2020-2025)
 Figure 54. Lipoid Revenue Growth Rate in Liposome Development Service Business (2020-2025)
 Figure 55. Polymun Scientific Revenue Growth Rate in Liposome Development Service Business (2020-2025)
 Figure 56. Corden Pharma Revenue Growth Rate in Liposome Development Service Business (2020-2025)
 Figure 57. Acuitas Therapeutics Revenue Growth Rate in Liposome Development Service Business (2020-2025)
 Figure 58. Creative Biolabs Revenue Growth Rate in Liposome Development Service Business (2020-2025)
 Figure 59. Creative Biostructure Revenue Growth Rate in Liposome Development Service Business (2020-2025)
 Figure 60. T&T Scientific Revenue Growth Rate in Liposome Development Service Business (2020-2025)
 Figure 61. FormuMax Scientific Revenue Growth Rate in Liposome Development Service Business (2020-2025)
 Figure 62. PlantaCorp Revenue Growth Rate in Liposome Development Service Business (2020-2025)
 Figure 63. CD Bioparticles Revenue Growth Rate in Liposome Development Service Business (2020-2025)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Liposomal Market Insights Forecast to 2030
Global liposomes in Skin Care Market Research Report 2025
Global Microsphere Liposomes Market Research Report 2024
Liposomal Drug delivery System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Liposome Assisted Drug Delivery Market Insights Forecast to 2030
Global Liposome for Cosmetic Ingredients Market Research Report 2025
Global Liposome Drug Delivery Market Insights Forecast to 2030
Liposomes Nanocarrier Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Lipid Contract Manufacturing Market Research Report 2024
Global Liposome Development and Manufacturing Service Market Research Report 2025
Liposomal and Lipid based Nanoparticle Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Liposomal based Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Liposomes for Cosmetics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Liposomes Nanoparticle Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Liposome Microsphere Market Research Report 2024
Liposome and Lipid Nanoparticle Finished Pharmaceuticals Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Liposomal and Lipid Drug Delivery Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Liposome Finished Pharmaceuticals Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Lipid Customization Service Market Research Report 2024
Liposome and Lipid Nanoparticle FDF Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global BPO in Public Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-17F6185
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Ultra-Thin Thermal Management Transfer Tape Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15E19879
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stencil Printer for Semiconductor Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29C17006
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gamification in Sports Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4X18374
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions